Exhaled breath condensate analysis from intubated newborns by nano-HPLC coupled to high resolution MS

Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences

Volumn 1047, Issue , 2017, Pages 97-105

  Kononikhin, A S ^a,b,e   Starodubtseva, N L ^a,b   Chagovets, V V ^a   Ryndin, A Y ^a   Burov, A A ^a   Popov, I A ^b,c,e   Bugrova, A E ^a,c   Dautov, R A ^b   Tokareva, A O ^b,e   Podurovskaya, Y L ^a   Ionov, O V ^a   Frankevich, V E ^a   Nikolaev, E N ^b,c,d,e   Sukhikh, G T ^a  

^a RESEARCH CENTER OF OBSTETRICS   (Russian Federation)

^b MOSCOW INSTITUTE OF PHYSICS AND TECHNOLOGY   (Russian Federation)

^c EMANUEL INSTITUTE OF BIOCHEMICAL PHYSICS   (Russian Federation)

^d SKOLKOVO INSTITUTE OF SCIENCE AND TECHNOLOGY   (Russian Federation)

^e SEMENOV INSTITUTE OF CHEMICAL PHYSICS   (Russian Federation)

Author keywords

Exhaled breath condensate (EBC); HPLC; Mass spectrometry; Metabolomics; Newborns; Pneumonia; Proteomic; Respiratory diseases

Indexed keywords

MASS SPECTROMETRY; METABOLITES; NONINVASIVE MEDICAL PROCEDURES; PROTEINS; PULMONARY DISEASES;

EXHALED BREATH CONDENSATE; HPLC; METABOLOMICS; NEWBORNS; PNEUMONIA; PROTEOMIC;

CONDENSATE TREATMENT;

ARTICLE; ARTIFICIAL VENTILATION; BODY FLUID; CLINICAL ARTICLE; CONGENITAL DIAPHRAGM HERNIA; EXHALED BREATH CONDENSATE; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; INTUBATION; MALE; MASS SPECTROMETRY; METABOLITE; METABOLOMICS; NEWBORN; PNEUMONIA; PRIORITY JOURNAL; PROTEOMICS; QUANTITATIVE ANALYSIS; REPRODUCIBILITY; SAMPLING; BREATH ANALYSIS; DEVICES; EQUIPMENT DESIGN; HERNIAS, DIAPHRAGMATIC, CONGENITAL; METABOLISM; METABOLOME;

BIOLOGICAL MARKER; PROTEIN;

BIOMARKERS; BREATH TESTS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; EQUIPMENT DESIGN; FEMALE; HERNIAS, DIAPHRAGMATIC, CONGENITAL; HUMANS; INFANT, NEWBORN; MALE; MASS SPECTROMETRY; METABOLOME; METABOLOMICS; PNEUMONIA; PROTEINS; PROTEOMICS; REPRODUCIBILITY OF RESULTS;

EID: 85009266755     PISSN: 15700232     EISSN: 1873376X     Source Type: Journal    
DOI: 10.1016/j.jchromb.2016.12.036     Document Type: Article

References (66)

1. [1] Stoll, B.J., Hansen, N.I., Bell, E.F., Shankaran, S., Laptook, A.R., Walsh, M.C., Hale, E.C., Newman, N.S., Schibler, K., Carlo, W.A., Kennedy, K.A., Poindexter, B.B., Finer, N.N., Ehrenkranz, R.A., Duara, S., Sanchez, P.J., O'Shea, T.M., Goldberg, R.N., Van Meurs, K.P., Faix, R.G., Phelps, D.L., Frantz, I.D. 3rd., Watterberg, K.L., Saha, S., Das, A., Higgins, R.D., Eunice, H., Kennedy Shriver National Institute of Child, N. Human Development Neonatal Research, Neonatal outcomes of extremely preterm infants from the NICHD Neonatal Research Network. Pediatrics 126 (2010), 443–456.
2. [2] Jobe, A.H., Ikegami, M., Prevention of bronchopulmonary dysplasia. Curr. Opin. Pediatr. 13 (2001), 124–129.
3. [3] Van Marter, L.J., Dammann, O., Allred, E.N., Leviton, A., Pagano, M., Moore, M., Martin, C., Developmental Epidemiology Network, Chorioamnionitis, mechanical ventilation, and postnatal sepsis as modulators of chronic lung disease in preterm infants. J. Pediatr. 140 (2002), 171–176.
4. [4] Bustani, P., Kotecha, S., Role of cytokines in hyperoxia mediated inflammation in the developing lung. ABBV Front Biosci 8 (2003), s694–704.
5. [5] Jobe, A.H., The new bronchopulmonary dysplasia. Curr. Opin. Pediatr. 23 (2011), 167–172.
6. [6] Viscardi, R.M., Perinatal inflammation and lung injury. Sem. Fetal Neonatal Med. 17 (2012), 30–35.
7. [7] Harwood, D.T., Darlow, B.A., Cheah, F.C., McNeill, N., Graham, P., Winterbourn, C.C., Biomarkers of neutrophil-mediated glutathione and protein oxidation in tracheal aspirates from preterm infants: association with bacterial infection. Pediatr. Res. 69 (2011), 28–33.
8. [8] Schneibel, K.R., Fitzpatrick, A.M., Ping, X.D., Brown, L.A., Gauthier, T.W., Inflammatory mediator patterns in tracheal aspirate and their association with bronchopulmonary dysplasia in very low birth weight neonates. J. Perinatol. 33 (2013), 383–387.
9. [9] Torrazza, R.M., Li, N., Young, C., Kobeissy, F., Chow, M., Chen, S.X., Mai, V., Sharma, R., Hudak, M., Shuster, J., Neu, J., Pilot study using proteomics to identify predictive biomarkers of necrotizing enterocolitis from buccal swabs in very low birth weight infants. Neonatology 104 (2013), 234–242.
10. [10] Starodubtseva, N.L., Kononikhin, A.S., Bugrova, A.E., Chagovets, V., Indeykina, M., Krokhina, K.N., Nikitina, I.V., Kostyukevich, Y.I., Popov, I.A., Larina, I.M., Timofeeva, L.A., Frankevich, V.E., Ionov, O.V., Degtyarev, D.N., Nikolaev, E.N., Sukhikh, G.T., Investigation of urine proteome of preterm newborns with respiratory pathologies. J. Proteom. 16 (2016), 30246–30249.
11. [11] Sylvester, K.G., Ling, X.F.B., Liu, G.Y.G., Kastenberg, Z.J., Ji, J., Hu, Z.K., Wu, S.B., Peng, S.H., Abdullah, F., Brandt, M.L., Ehrenkranz, R.A., Harris, M.C., Lee, T.C., Simpson, B.J., Bowers, C., Moss, R.L., Urine protein biomarkers for the diagnosis and prognosis of necrotizing enterocolitis in infants. J. Pediatr-Us, 164, 2014, 607-.
12. [12] Decramer, S., Zurbig, P., Wittke, S., Mischak, H., Bascands, J.L., Schanstra, J.P., Identification of urinary biomarkers by proteomics in newborns: use in obstructive nephropathy. Contrib. Nephrol. 160 (2008), 127–141.
13. [13] Lacroix, C., Caubet, C., Gonzalez-de-Peredo, A., Breuil, B., Bouyssie, D., Stella, A., Garrigues, L., Le Gall, C., Raevel, A., Massoubre, A., Klein, J., Decramer, S., Sabourdy, F., Bandin, F., Burlet-Schiltz, O., Monsarrat, B., Schanstra, J.P., Bascands, J.L., Label-free quantitative urinary proteomics identifies the arginase pathway as a new player in congenital obstructive nephropathy. Mol. Cell. Proteomics 13 (2014), 3421–3434.
14. [14] Kuban, P., Foret, F., Exhaled breath condensate: determination of non-volatile compounds and their potential for clinical diagnosis and monitoring. A review. Anal. Chim. Acta 805 (2013), 1–18.
15. [15] Chagovets, V., Kononikhin, A., Starodubtseva, N., Ding, J., Chen, H., Frankevich, V., Letter Comparison of pyridine and pyrazine derivatives distributions in exhaled breath and exhaled breath condensate after smoking. Eur. J. Mass Spectrom. 21 (2015), 829–832.
16. [16] Kononikhin, A.S., Fedorchenko, K.Y., Ryabokon, A.M., Starodubtseva, N.L., Popov, I.A., Zavialova, M.G., Anaev, E.C., Chuchalin, A.G., Varfolomeev, S.D., Nikolaev, E.N., Proteomic analysis of exhaled breath condensate for diagnostics of respiratory system diseases. Biochem. (Moscow) Suppl. Series B: Biomed. Chem. 10 (2016), 230–234.
17. [17] Horvath, I., de Jongste, J., Exhaled biomarkers. Eur. Respir. Soc. Monogr. 49 (2010), 1–31.
18. [18] Agapiou, A., Amann, A., Mochalski, P., Statheropoulos, M., Thomas, C.L.P., Trace detection of endogenous human volatile organic compounds for search, rescue and emergency applications. Trends Anal. Chem. 66 (2015), 158–175.
19. [19] Brunetti, L., Francavilla, R., Tesse, R., Fiermonte, P., Fiore, F.P., Lore, M., Margiotta, M., Armenio, L., Exhaled breath condensate cytokines and pH in pediatric asthma and atopic dermatitis. Allergy Asthma Proc. 29 (2008), 461–467.
20. [20] Konstantinidi, E.M., Lappas, A.S., Tzortzi, A.S., Behrakis, P.K., Exhaled Breath condensate: technical and diagnostic aspects. Sci. World J., 2015, 2015, 435160.
21. [21] Moeller, A., Franklin, P., Hall, G.L., Horak, F. Jr., Wildhaber, J.H., Stick, S.M., Measuring exhaled breath condensates in infants. Pediatr. Pulmonol. 41 (2006), 184–187.
22. [22] Filippone, M., Bonetto, G., Corradi, M., Frigo, A.C., Baraldi, E., Evidence of unexpected oxidative stress in airways of adolescents born very pre-term. Eur. Respir. J. 40 (2012), 1253–1259.
23. [23] Fanos, V., Antonucci, R., Barberini, L., Noto, A., Atzori, L., Clinical application of metabolomics in neonatology. J. Mater. Fetal Neonatal Med. 25:Suppl. 1 (2012), 104–109.
24. [24] Fanos, V., Barberini, L., Antonucci, R., Atzori, L., Metabolomics in neonatology and pediatrics. Clin. Biochem. 44 (2011), 452–454.
25. [25] Carraro, S., Folesani, G., Corradi, M., Zanconato, S., Gaston, B., Baraldi, E., Acid-base equilibrium in exhaled breath condensate of allergic asthmatic children. Allergy 60 (2005), 476–481.
26. [26] Brunetti, L., Francavilla, R., Tesse, R., Strippoli, A., Polimeno, L., Loforese, A., Miniello, V.L., Armenio, L., Exhaled breath condensate pH measurement in children with asthma, allergic rhinitis and atopic dermatitis. Pediatric Allergy Immunol. 17 (2006), 422–427.
27. [27] Carraro, S., Giordano, G., Reniero, F., Carpi, D., Stocchero, M., Sterk, P.J., Baraldi, E., Asthma severity in childhood and metabolomic profiling of breath condensate. Allergy 68 (2013), 110–117.
28. [28] Montuschi, P., Paris, D., Melck, D., Lucidi, V., Ciabattoni, G., Raia, V., Calabrese, C., Bush, A., Barnes, P.J., Motta, A., NMR spectroscopy metabolomic profiling of exhaled breath condensate in patients with stable and unstable cystic fibrosis. Thorax 67 (2012), 222–228.
29. [29] van Mastrigt, E., de Jongste, J.C., Pijnenburg, M.W., The analysis of volatile organic compounds in exhaled breath and biomarkers in exhaled breath condensate in children − clinical tools or scientific toys?. Clin. Exp. Allergy 45 (2015), 1170–1188.
30. [30] Caffarelli, C., Calcinai, E., Rinaldi, L., Povesi Dascola, C., Terracciano, L., Corradi, M., Hydrogen peroxide in exhaled breath condensate in asthmatic children during acute exacerbation and after treatment. Respir; Int. Rev. Thor. Dis. 84 (2012), 291–298.
31. [31] Robroeks, C.M., van Vliet, D., Jobsis, Q., Braekers, R., Rijkers, G.T., Wodzig, W.K., Bast, A., Zimmermann, L.J., Dompeling, E., Prediction of asthma exacerbations in children: results of a one-year prospective study. Clin. Exp. Allergy 42 (2012), 792–798.
32. [32] Carraro, S., Giordano, G., Piacentini, G., Kantar, A., Moser, S., Cesca, L., Berardi, M., Di Gangi, I.M., Baraldi, E., Asymmetric dimethylarginine in exhaled breath condensate and serum of children with asthma. Chest 144 (2013), 405–410.
33. [33] Hasan, R.A., O'Brien, E., Mancuso, P., Lipoxin, A., (4) and 8-isoprostane in the exhaled breath condensate of children hospitalized for status asthmaticus. Pediatric Crit. Care Med. 13 (2012), 141–145.
34. [34] Debley, J.S., Cochrane, E.S., Redding, G.J., Carter, E.R., Lung function and biomarkers of airway inflammation during and after hospitalization for acute exacerbations of childhood asthma associated with viral respiratory symptoms. Ann. Allergy Asthma Immunol. 109 (2012), 114–120.
35. [35] Karakoc, G.B., Yukselen, A., Yilmaz, M., Altintas, D.U., Kendirli, S.G., Exhaled breath condensate MMP-9 level and its relationship with asthma severity and interleukin-4/10 levels in children. Ann. Allergy Asthma Immunol. 108 (2012), 300–304.
36. [36] Leung, T.F., Wong, G.W., Ko, F.W., Lam, C.W., Fok, T.F., Increased macrophage-derived chemokine in exhaled breath condensate and plasma from children with asthma. Clin. Exp. Allergy 34 (2004), 786–791.
37. [37] Corradi, M., Folesani, G., Andreoli, R., Manini, P., Bodini, A., Piacentini, G., Carraro, S., Zanconato, S., Baraldi, E., Aldehydes and glutathione in exhaled Breath condensate of children with asthma exacerbation. Am. J. Respir. Crit. Care Med. 167 (2003), 395–399.
38. [38] Baraldi, E., Filippone, M., Chronic lung disease after premature birth. N. Engl. J. Med. 357 (2007), 1946–1955.
39. [39] Cheah, F.C., Darlow, B.A., Winterbourn, C.C., Association of hydrogen peroxide in exhaled breath condensates from infants with respiratory distress syndrome with the development of chronic lung disease. Arch. Dis. Child. Fetal Neonatal Ed., 91, 2006, F155.
40. [40] Rosso, M.I., Roark, S., Taylor, E., Ping, X., Ward, J.M., Roche, K., McCracken, C., Brown, L.A., Gauthier, T.W., Exhaled breath condensate in intubated neonates–a window into the lung's glutathione status. Respir. Res., 15, 2014, 1.
41. [41] Hitka, P., Cerny, M., Vizek, M., Wilhelm, J., Zoban, P., Assessment of exhaled gases in ventilated preterm infants. Physiol. Res. Acad. Sci. Bohemoslov. 53 (2004), 561–564.
42. [42] Jain, A., Mehta, T., Auld, P.A., Rodrigues, J., Ward, R.F., Schwartz, M.K., Martensson, J., Glutathione metabolism in newborns: evidence for glutathione deficiency in plasma, bronchoalveolar lavage fluid, and lymphocytes in prematures. Pediatr. Pulmonol. 20 (1995), 160–166.
43. [43] Harrison, C.M., Andersen, C.C., Exhaled breath measures of inflammation: are they useful in neonatal chronic lung disease?, Archives of disease in childhood. Fetal Neonatal Ed. 90 (2005), F6–10.
44. [44] Kurova, V.S., Anaev, E.C., Kononikhin, A.S., Fedorchenko, K.Y., Popov, I.A., Kalupov, T.L., Bratanov, D.O., Nikolaev, E.N., Varfolomeev, S.D., Proteomics of exhaled breath: methodological nuances and pitfalls. Clin. Chem. Lab. Med. 47 (2009), 706–712.
45. [45] Kurova, V.S., Kononikhin, A.S., Sakharov, D.A., Popov, I.A., Larina, I.M., Tonevitskii, A.G., Varfolomeev, S.D., Nikolaev, E.N., Exogenic proteins in the human exhaled breath condensate. Bioorg. Khim. 37 (2011), 55–60.
46. [46] Thevenot, E.A., Roux, A., Xu, Y., Ezan, E., Junot, C., Analysis of the human adult urinary metabolome variations with age, body mass index, and gender by implementing a comprehensive workflow for univariate and OPLS statistical analyses. J. Proteome Res. 14 (2015), 3322–3335.
47. [47] Hoffmann, H.J., Tabaksblat, L.M., Enghild, J.J., Dahl, R., Human skin keratins are the major proteins in exhaled breath condensate. Eur. Respir. J. 31 (2008), 380–384.
48. [48] Gessner, C., Dihazi, H., Brettschneider, S., Hammerschmidt, S., Kuhn, H., Eschrich, K., Keller, T., Engelmann, L., Sack, U., Wirtz, H., Presence of cytokeratins in exhaled breath condensate of mechanical ventilated patients. Respir. Med. 102 (2008), 299–306.
49. [49] Griese, M., Noss, J., von Bredow, C., Protein pattern of exhaled breath condensate and saliva. Proteomics 2 (2002), 690–696.
50. [50] Samitas, K., Zervas, E., Vittorakis, S., Semitekolou, M., Alissafi, T., Bossios, A., Gogos, H., Economidou, E., Lotvall, J., Xanthou, G., Panoutsakopoulou, V., Gaga, M., Osteopontin expression and relation to disease severity in human asthma. Eur. Respir. J. 37 (2011), 331–341.
51. [51] Wang, K.X., Denhardt, D.T., Osteopontin: role in immune regulation and stress responses. Cytok. Growth Factor Rev. 19 (2008), 333–345.
52. [52] Samitas, K., Zervas, E., Xanthou, G., Panoutsakopoulou, V., Gaga, M., Osteopontin is increased in the bronchoalveolar lavage fluid and bronchial tissue of smoking asthmatics. Cytokine 61 (2013), 713–715.
53. [53] McAuley, J.L., Linden, S.K., Png, C.W., King, R.M., Pennington, H.L., Gendler, S.J., Florin, T.H., Hill, G.R., Korolik, V., McGuckin, M.A., MUC1 cell surface mucin is a critical element of the mucosal barrier to infection. J. Clin. Invest. 117 (2007), 2313–2324.
54. [54] Singh, A.P., Chaturvedi, P., Batra, S.K., Emerging roles of MUC4 in cancer: a novel target for diagnosis and therapy. Cancer Res. 67 (2007), 433–436.
55. [55] Butler, M.W., Fukui, T., Salit, J., Shaykhiev, R., Mezey, J.G., Hackett, N.R., Crystal, R.G., Modulation of cystatin A expression in human airway epithelium related to genotype, smoking, COPD, and lung cancer. Cancer Res. 71 (2011), 2572–2581.
56. [56] Carpagnano, G.E., Kharitonov, S.A., Wells, A.U., Pantelidis, P., Du Bois, R.M., Barnes, P.J., Increased vitronectin and endothelin-1 in the breath condensate of patients with fibrosing lung disease. Respir; Int. Rev. Thor. Dis. 70 (2003), 154–160.
57. [57] McGreevy, E.M., Vijayraghavan, D., Davidson, L.A., Hildebrand, J.D., Shroom3 functions downstream of planar cell polarity to regulate myosin II distribution and cellular organization during neural tube closure. Biol. Open 4 (2015), 186–196.
58. [58] Spiteller, P., Kern, W., Reiner, J., Spiteller, G., Aldehydic lipid peroxidation products derived from linoleic acid. Biochim. Biophys. Acta 1531 (2001), 188–208.
59. [59] Shimozu, Y., Hirano, K., Shibata, T., Shibata, N., Uchida, K., 4-Hydroperoxy-2-nonenal is not just an intermediate but a reactive molecule that covalently modifies proteins to generate unique intramolecular oxidation products. J. Biol. Chem. 286 (2011), 29313–29324.
60. [60] Carraro, S., Giordano, G., Pirillo, P., Maretti, M., Reniero, F., Cogo, P.E., Perilongo, G., Stocchero, M., Baraldi, E., Airway metabolic anomalies in adolescents with bronchopulmonary dysplasia: new insights from the metabolomic approach. J. Pediatr. 166 (2015), 234–239 (e231).
61. [61] Wheelock, C.E., Goss, V.M., Balgoma, D., Nicholas, B., Brandsma, J., Skipp, P.J., Snowden, S., Burg, D., D'Amico, A., Horvath, I., Chaiboonchoe, A., Ahmed, H., Ballereau, S., Rossios, C., Chung, K.F., Montuschi, P., Fowler, S.J., Adcock, I.M., Postle, A.D., Dahlen, S.E., Rowe, A., Sterk, P.J., Auffray, C., Djukanovic, R., Group, U.B.S., Application of ‘omics technologies to biomarker discovery in inflammatory lung diseases. Eur. Respir. J. 42 (2013), 802–825.
62. [62] Khanapure, S.P., Garvey, D.S., Janero, D.R., Letts, L.G., Eicosanoids in inflammation: biosynthesis, pharmacology, and therapeutic frontiers. Curr. Top. Med. Chem. 7 (2007), 311–340.
63. [63] Fang, X., Kaduce, T.L., Weintraub, N.L., Harmon, S., Teesch, L.M., Morisseau, C., Thompson, D.A., Hammock, B.D., Spector, A.A., Pathways of epoxyeicosatrienoic acid metabolism in endothelial cells. Implications for the vascular effects of soluble epoxide hydrolase inhibition. J. Biol. Chem. 276 (2001), 14867–14874.
64. [64] Bernhard, W., Pynn, C.J., Jaworski, A., Rau, G.A., Hohlfeld, J.M., Freihorst, J., Poets, C.F., Stoll, D., Postle, A.D., Mass spectrometric analysis of surfactant metabolism in human volunteers using deuteriated choline. Am. J. Respir. Crit. Care Med. 170 (2004), 54–58.
65. [65] Gueraud, F., Atalay, M., Bresgen, N., Cipak, A., Eckl, P.M., Huc, L., Jouanin, I., Siems, W., Uchida, K., Chemistry and biochemistry of lipid peroxidation products. Free Radic. Res. 44 (2010), 1098–1124.
66. [66] Williams, M.V., Wishnok, J.S., Tannenbaum, S.R., Covalent adducts arising from the decomposition products of lipid hydroperoxides in the presence of cytochrome c. Chem. Res. Toxicol. 20 (2007), 767–775.